Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1

Journal of Biological Chemistry

Volumn 289, Issue 21, 2014, Pages 14520-14533

  Bao, Bin ^a   Azmi, Asfar S ^a   Aboukameel, Amro ^b   Ahmad, Aamir ^a   Bolling Fischer, Aliccia ^b   Sethi, Seema ^a   Ali, Shadan ^b   Li, Yiwei ^a   Kong, Dejuan ^a   Banerjee, Sanjeev ^a   Back, Jessica ^b   Sarkar, Fazlul H ^a,b  

^a KARMANOS CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; GENE EXPRESSION; STEM CELLS; TUMORS;

CANCER STEM CELLS; CELL LINES; CLINICAL OUTCOME; DIFFERENTIAL EXPRESSIONS; PANCREATIC CANCERS; TREATMENT OUTCOMES;

DISEASES;

EPITHELIAL CELL ADHESION MOLECULE; FORKHEAD BOX Q1 TRANSCRIPTION FACTOR; FORKHEAD TRANSCRIPTION FACTOR; MESSENGER RNA; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER STEM CELL; CANCER STEM LIKE CELL; CANCER TISSUE; CELL FUNCTION; CELL GROWTH; CELL ISOLATION; CELL MIGRATION; CELL RENEWAL; CLONOGENESIS; CONTROLLED STUDY; FOXQ1 GENE; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; L3.6PL CELL LINE; MIAPACA 2 CELL LINE; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; TUMOR GENE; TUMOR GROWTH; TUMOR XENOGRAFT;

CANCER STEM CELLS; CD44; FLOW CYTOMETRY; GENE EXPRESSION; MICROARRAY; PANCREATIC CANCER; SIRNA; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; ANTIGENS, NEOPLASM; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, SCID; MICROSCOPY, CONFOCAL; NEOPLASTIC STEM CELLS; PANCREATIC NEOPLASMS; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTIONAL ACTIVATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84901465771     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.532887     Document Type: Article

References (34)

1. Bonnet, D., and Dick, J. E. (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730-737 . (Pubitemid 27298715)
2. Hermann, P. C., Mueller, M. T., and Heeschen, C. (2009) Pancreatic cancer stem cells: insights and perspectives. Expert Opin. Biol. Ther. 9, 1271-1278 .
3. Li, Y., Kong, D., Ahmad, A., Bao, B., and Sarkar, F. H. (2013) Pancreatic cancer stem cells: emerging target for designing novel therapy. Cancer Lett. 338, 94-100 .
4. Sarkar, F. H., Li, Y., Wang, Z., and Kong, D. (2009) Pancreatic cancer stem cells and EMT in drug resistance and metastasis. Minerva Chir. 64, 489-500 .
5. Siegel, R., Naishadham, D., and Jemal, A. (2013) Cancer statistics, 2013. CA Cancer J. Clin. 63, 11-30 .
6. Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., and Heeschen, C. (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1, 313-323 . (Pubitemid 47355323)
7. Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., and Simeone, D. M. (2007) Identification of pancreatic cancer stem cells. Cancer Res. 67, 1030-1037 .
8. Bao, B., Ali, S., Kong, D., Sarkar, S. H., Wang, Z., Banerjee, S., Aboukameel, A., Padhye, S., Philip, P. A., and Sarkar, F. H. (2011) Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer. PLoS One 6, e17850 .
9. Bao, B., Ali, S., Banerjee, S., Wang, Z., Logna, F., Azmi, A. S., Kong, D., Ahmad, A., Li, Y., Padhye, S., and Sarkar, F. H. (2012) Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Res. 72, 335-345 .
10. Yin, S., Li, J., Hu, C., Chen, X., Yao, M., Yan, M., Jiang, G., Ge, C., Xie, H., Wan, D., Yang, S., Zheng, S., and Gu, J. (2007) CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int. J. Cancer 120, 1444-1450 . (Pubitemid 46355378)
11. Ali, S., Ahmad, A., Banerjee, S., Padhye, S., Dominiak, K., Schaffert, J. M., Wang, Z., Philip, P. A., and Sarkar, F. H. (2010) Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Res. 70, 3606-3617 .
12. Kong, D., Banerjee, S., Ahmad, A., Li, Y., Wang, Z., Sethi, S., and Sarkar, F. H. (2010) Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One 5, e12445 .
13. van Vlerken, L. E., Kiefer, C. M., Morehouse, C., Li, Y., Groves, C., Wilson, S. D., Yao, Y., Hollingsworth, R. E., and Hurt, E. M. (2013) EZH2 is required for breast and pancreatic cancer stem cell maintenance and can be used as a functional cancer stem cell reporter. Stem Cells Transl. Med. 2, 43-52 .
14. Feng, J., Zhang, X., Zhu, H., Wang, X., Ni, S., and Huang, J. (2012) FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT. PLoS One 7, e39937 .
15. Liang, S. H., Yan, X. Z., Wang, B. L., Jin, H. F., Yao, L. P., Li, Y. N., Chen, M., Nie, Y. Z., Wang, X., Guo, X. G., Wu, K. C., Ding, J., and Fan, D. M. (2013) Increased expression of FOXQ1 is a prognostic marker for patients with gastric cancer. Tumour Biol. 34, 2605-2609 .
16. Kaneda, H., Arao, T., Tanaka, K., Tamura, D., Aomatsu, K., Kudo, K., Sakai, K., De Velasco, M. A., Matsumoto, K., Fujita, Y., Yamada, Y., Tsurutani, J., Okamoto, I., Nakagawa, K., and Nishio, K. (2010) FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth. Cancer Res. 70, 2053-2063 .
17. Hermann, P. C., Bhaskar, S., Cioffi, M., and Heeschen, C. (2010) Cancer stem cells in solid tumors. Semin. Cancer Biol. 20, 77-84 .
18. Sun, H. T., Cheng, S. X., Tu, Y., Li, X. H., and Zhang, S. (2013) FoxQ1 promotes glioma cells proliferation and migration by regulating NRXN3 expression. PLoS One 8, e55693 .
19. Xia, L., Huang, W., Tian, D., Zhang, L., Qi, X., Chen, Z., Shang, X., Nie, Y., and Wu, K. (2014) FoxQ1 promotes hepatocellular carcinoma metastasis by trans-activating ZEB2 and VersicanV1 expression. Hepatology 59, 958-973 .
20. Zhang, H., Meng, F., Liu, G., Zhang, B., Zhu, J., Wu, F., Ethier, S. P., Miller, F., and Wu, G. (2011) Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res. 71, 1292-1301 .
21. Zhu, Z., Zhu, Z., Pang, Z., Xing, Y., Wan, F., Lan, D., and Wang, H. (2013) Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer. Int. J. Oncol. 42, 1271-1278 .
22. Kallioniemi, A. (2012) Bone morphogenetic protein 4: a fascinating regulator of cancer cell behavior. Cancer Genet. 205, 267-277 .
23. Katoh, Y., and Katoh, M. (2009) Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr. Mol. Med. 9, 873-886 .
24. Katoh, Y., and Katoh, M. (2006) Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review). Int. J. Mol. Med. 18, 1019-1023 .
25. Altaner, C. (2008) Glioblastoma and stem cells. Neoplasma 55, 369-374 .
26. Villageois, P., Wdziekonski, B., Zaragosi, L. E., Plaisant, M., Mohsen-Kanson, T., Lay, N., Ladoux, A., Peraldi, P., and Dani, C. (2012) Regulators of human adipose-derived stem cell self-renewal. Am. J. Stem Cells 1, 42-47 .
27. Vicente López, M. A., Vázquez García, M. N., Entrena, A., Olmedillas Lopez, S., García-Arranz, M., García-Olmo, D., and Zapata, A. (2011) Low doses of bone morphogenetic protein 4 increase the survival of human adipose-derived stem cells maintaining their stemness and multipotency. Stem Cells Dev. 20, 1011-1019 .
28. Ma, W., Ma, J., Xu, J., Qiao, C., Branscum, A., Cardenas, A., Baron, A. T., Schwartz, P., Maihle, N. J., and Huang, Y. (2013) Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironment. Cell Cycle 12, 88-97 .
29. Allard, J. E., Risinger, J. I., Morrison, C., Young, G., Rose, G. S., Fowler, J., Berchuck, A., and Maxwell, G. L. (2007) Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas. Gynecol. Oncol. 107, 52-57. (Pubitemid 47464540)
30. D'Angelica, M., Ammori, J., Gonen, M., Klimstra, D. S., Low, P. S., Murphy, L., Weiser, M. R., Paty, P. B., Fong, Y., Dematteo, R. P., Allen, P., Jarnagin, W. R., and Shia, J. (2011) Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance. Mod. Pathol. 24, 1221-1228 .
31. Ebel, W., Routhier, E. L., Foley, B., Jacob, S., McDonough, J. M., Patel, R. K., Turchin, H. A., Chao, Q., Kline, J. B., Old, L. J., Phillips, M. D., Nicolaides, N. C., Sass, P. M., and Grasso, L. (2007) Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-α. Cancer Immun. 7, 6 .
32. Toffoli, G., Russo, A., Gallo, A., Cernigoi, C., Miotti, S., Sorio, R., Tumolo, S., and Boiocchi, M. (1998) Expression of folate-binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer. Int. J. Cancer 79, 121-126 . (Pubitemid 28201681)
33. Wood, L. D. (2012) Folate receptorα: a new tool in the diagnosis and treatment of lung cancer. Oncotarget 3, 668-669 .
34. Clarhaut, J., Fraineau, S., Guilhot, J., Peraudeau, E., Tranoy-Opalinski, I., Thomas, M., Renoux, B., Randriamalala, E., Bois, P., Chatelier, A., Monvoisin, A., Cronier, L., Papot, S., and Guilhot, F. (2013) A galactosidaseresponsive doxorubicin-folate conjugate for selective targeting of acute myelogenous leukemia blasts. Leuk. Res. 37, 948-955 .